Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma

NCT05351931 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Anal Cancer

Interventions

DIETARY_SUPPLEMENT: Salovum and SPC-flakes or corresponding placebo

Sponsor

Uppsala University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]